The FBI and the Terrorist Lone Wolfies at Yale (hilarious)
Kathleen
margaret...@fda.hhs.gov, dwh...@forbes.com,
ca...@drcarolgoodheart.com, lPick...@cdc.gov, Durlan...@yale.edu,
Aa...@columbia.edu, gary_w...@nymc.edu,
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, margaret...@hhs.fds.gov,
emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@ct.gov, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@ct.gov, kur...@washpost.com, georg...@washpost.com,
p...@allegorypress.com, commissi...@po.state.ct.us,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@ct.gov,
randall...@usdoj.gov, Robert....@yale.edu, editor@greenwich-
post.com, harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, saint....@sbcglobal.net
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, bmi...@newstimes.com, tr...@hotmail.com,
rast...@aol.com, billc...@gmail.com, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com
Subject: The FBI and the Terrorist Lone Wolfies at Yale (hilarious)
Date: Oct 9, 2011 3:17 AM
ARTICLE BELOW
=================================
Well, what could be worse than the 35 years
of lies about Lyme and LYMErix?
The CDC has been kicked out of the biodefense
loop, formally, by the US Military, and the Nobel
Prize in Medicine going to the peeps who revealed
that TLR2 agonism is the complete opposite of
a vaccine, and the key to nearly all diseases
("adaptive immunity"); See:
http://www.actionlyme.org
Terrorists?
Deploying Biological Weapons?
Violence?
RICO-esque persecutions and coercion?
That was Yale and the CDC.
But *now* the US Military and the NIH
want nothing to do with them because...
"Why, one might ask, would the military be interested in such an
enterprise? In a 16 September media release, the Pentagon minces no
words on that question: '***The Department of Defense needs to rapidly
develop and field safe and effective medical countermeasures against
biological threats to U.S. warfighters***.'
http://blogs.nature.com/news/2011/09/drug_safety_on_a_chip_1.html
Which ^^^ is completely the opposite of
the crazy and criminal Dearborn
Diagnostic standard for "Lyme Disease."
This is a global pandemic and the Nobels
in Medicine went to the peeps who revealed
how LYMErix could never have been a vaccine
and that the lies about it performed by
Yale staff inhibited all these discoveries
about cancer (activated Epstein-Barr),
Multiple Sclerosis, Lupus, etc, for
the last 15 years.
Good thing it did not take 50.
Imagine the advantage these LYMErix lies
would have given the Chinese and Russians,...
since they've paid attention to the
Lyme crimes all along.
And Europe is now insisting that all Borrelial
infections be identified as "RELAPSING FEVER"
as a diagnosis and physiology)once again.
:)))
- - - - -
Oh, and the whole world knows about
mycoplasmal contaminants in childhood
vaccine vials, too, BTW.
Big threat. Everyone in the whole
world knows the CDC is full of crap
in more ways than one.
The whole world knows that the CDC is
Disease Counterintelligence.
Perfect.
http://www.actionlyme.org
KMDickson
================================
http://www.globalsecuritynewswire.org/gsn/nw_20111005_2679.php
WASHINGTON -- A decade after the deadly anthrax mailings of 2001, the
United States is more ready to rapidly distribute medical
countermeasures to save a population or a large city in the event of a
major biological strike, key Obama administration officials said on
Tuesday (see GSN, Oct. 4).
(Oct. 5) - U.S. military personnel take mock anthrax samples during a
2007 exercise. The United States has bolstered its preparedness since
2001 to quickly disperse medical countermeasures to a large number of
people following a potential bioterrorism event, senior Obama
administration officials said on Tuesday (U.S. Navy photo).
"We're definitely better prepared now than we ever have been," Thomas
Frieden, director of the Centers for Disease Control and Prevention,
said during a panel discussion hosted by University of Pittsburgh's
Center for Biosecurity.
Countermeasures from the U.S. Strategic National Stockpile are
intended to reach potential victims of a biological or other WMD event
within 48 hours. In that vein, six metropolitan areas recently
received grant funds from the Health and Human Services Department to
prepare volunteer U.S. Postal Service mail carriers to deliver anthrax
medications to area residents (see GSN, Aug. 25).
Frieden said that more states have established the capacities to
detect potentially lethal biological outbreaks and to respond quickly
with vaccines. He specifically noted the H1N1 influenza outbreaks in
2009, during which some localities used football stadiums and drive-
through pharmacies to vaccinate large numbers of people.
Still, anthrax and other "worst-case scenarios" continue to challenge
health officials "in terms of what is a realistic expectation of what
we can do and what we can do that will cause no harm," according to
Frieden.
Health and Human Services recently completed an exercise in Los
Angeles that examined what federal resources might be brought to bear
in the event of a domestic biological emergency, according to Nicole
Lurie, assistant secretary for preparedness and response.
The demonstration exposed gaps in the number of federal health
responders available to assist in such an event, she added without
providing a specific figure. The health agency plans to work with the
Defense Department and the private sector to address the shortfall,
Lurie said.
A key reason why the federal government is better prepared than other
nations to respond to an anthrax strike is because it already
experienced one, Andrew Weber, assistant to the Defense secretary on
nuclear, chemical and biological programs, told the audience.
"Sadly, we had the luxury of an attack in this country 10 years ago
that accelerated the process of interagency partnership on the
biological threat space," he said.
Early last year the FBI formally closed an eight-year investigation
that identified Army scientist Bruce Ivins as the perpetrator of the
anthrax mailings that killed five people and infected 17 others. Ivins
committed suicide before facing charges.
Weber said today's biological threat "really depends on the adversary
we're thinking about."
A small terrorist group with proven intent to use pathogens is likely
to employ anthrax, botulinum toxin or ricin, he said. However, if it
originates from a state with a biological weapons program "it's the
unknowns."
"They know our list, they know our capabilities. It doesn't take a
genius to figure out they may use something that's not on our list,"
Weber said. "We need to work both of those. We still have a lot to do
against the simpler cases."
Weber said that the 2001 attacks show that "the potential for a lone-
wolf bioterrorist or a small group mounting such an attack is not a
hypothetical."
Since the attacks the federal government has spent what observers
estimate to be billions of dollars to prepare against biological
threats. In 2003 the existing National Pharmaceutical Stockpile was
transformed into the Strategic National Stockpile to store medical
supplies in the event of a bioterrorism incident or other public
health emergency.
Congress in 2004 established Project Bioshield, which was intended to
receive about $5.6 billion over 10 years to purchase medicines to
protect U.S. citizens from the effects of a WMD attack. The program
was designed to provide biotechnology and pharmaceutical companies
with confidence that the federal government would buy successful
vaccines, bolstering those firms' willingness to pursue such products.
The effort to date has bought more than $2 billion of countermeasures
for the national stockpile but has had mixed success.
In 2010 the Obama administration launched the nearly $2 billion
Medical Countermeasures Initiative as a response to the government's
slower-than-expected response to the H1N1 influenza outbreaks. The
program calls for the Health and Human Services and Defense
departments each to establish their own center of excellence for
vaccine development and production to combat disease pandemics.
Both Weber and Lurie touted the benefits the facilities would provide
in the future, adding that both agencies are involved in the
development of the other's site. They did not say when the sites would
be up and running.
Weber said the two departments are "attached at the hip" on
implementation of the vaccine overhaul. He noted that the Pentagon
recently issued the first request for proposals for the facility.
Health and Human Services has already closed the application process
for its proposal and is reviewing the submissions, Lurie told Global
Security Newswire after the discussion. The department hopes to award
the contract in 2012, she said.
Weber said two separate facilities are required because each
department has different needs. For example, while both will use FDA-
approved drugs, the dosages are different for U.S. armed forces and
the general population, he said.
In addition, during peacetime the Pentagon places a higher premium on
preventive medicine and care, according to Weber, citing the
vaccination of troops against smallpox.
Additional Preparedness
Last week the National Academies' Institute of Medicine released a
report that said local and state public health authorities are best
suited to determine the location and method for holding antibiotics to
be disseminated in the wake of a possible anthrax attack (see GSN,
Oct. 3).
Frieden said federal health officials understand that prepositioning
medications for a natural or man-made disease outbreak "has a lot of
appeal and it might be the right answer for some populations and some
communities."
He cautioned, though, that recent studies also show that "people
rapidly forget where they've put [the vaccine], they take it when they
shouldn't, they give it to people who shouldn't have it, it expires or
it gets put into places where it decays rapidly."
The CDC chief stressed that all levels of government focus on
preparedness, not "buying huge chunks of an item and keeping it in
place."
The fact that there has not been another domestic bioterrorism attack
in almost 10 years should not lead governments at all levels to stop
investing in preparedness measures, according to Lurie
"I don't think we should take our foot off the gas here," she said.
She added that while there have been a series of successful
counterterrorism efforts, such as the drone killing Yemeni-U.S. cleric
Anwar al-Awlaki on Sept. 30, "we just don't know what might happen in
terms of the inevitable."
KMDickson